Results 241 to 250 of about 253,192 (255)

Soluble human interleukin-6-receptor modulates interleukin-6-dependent N-glycosylation of α1-protease inhibitor secreted by HepG2 cells

FEBS Letters, 1992
Andrzej Mackiewicz, Stefan Rose-John, Peter C Heinrich   +2 more
exaly  

Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4

Bioorganic and Medicinal Chemistry Letters, 2006
Zhulun Wang, Holger Wesche, Jay P Powers
exaly  

Interleukin-1 receptor associated kinase inhibitors: Potential therapeutic agents for inflammatory- and immune-related disorders

Cellular Signalling, 2015
Om Silakari, Maninder Kaur, Malkeet Singh Bahia   +2 more
exaly  

Circulating Levels of Interleukin 1-Receptor Antagonist and Risk of Cardiovascular Disease

Arteriosclerosis, Thrombosis, and Vascular Biology, 2017
Abbas Dehghan, Annette Peters, Veikko Salomaa   +2 more
exaly  

AGENT FOR TREATMENT OF OPHTHALMIA CONTAINING INTERLEUKIN-6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT

2009
OHGURO NOBUYUKI, TANO YASUO, SONODA KOHEI, ISHIBASHI TATSURO   +3 more
openaire   +2 more sources

Recent advances in interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors and PROTACs

Chinese Chemical Letters
Chengjuan Chen, Hai-Yu Hu, Lan Sun
exaly  

Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet’s disease

Rheumatology International, 2003
Nursen Düzgün, Ergin Ayaşlioğlu
exaly  

Interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors: an updated patent review (2016-2018)

Expert Opinion on Therapeutic Patents, 2019
exaly  

Swainsonine, an inhibitor of glycoprotein processing, enhances mitogen induced interleukin 2 production and receptor expression in human lymphocytes

Biochemical and Biophysical Research Communications, 1988
Terry L Bowlin, P S Sunkara, T L Bowlin
exaly  

THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT

2017
OHGURO NOBUYUKI, TANO YASUO, SONODA KOHEI, ISHIBASHI TATSURO   +3 more
openaire   +2 more sources